Skip to main content
. 2015 Dec;15(6):536–540. doi: 10.7861/clinmedicine.15-6-536

Table 1.

Characteristics of study subjects.

Characteristic Value
Male, n (%) 20 (50.0)
Female, n (%) 20 (50.0)
Age in years, mean (range) [SD] 61 (22–90) [12]
Weight in kg, mean (range) [SD] 71.2 (32.7–109.3) [18.3]
Body mass index in kg/m2, mean (range) [SD] 25.5 (12.8–38.1) [5.2]
Treatment
 Previous GI surgery, n (%) 22 (55.0)
 GI luminal surgery, n (%)a 15 (37.5)
 Cholecystectomy, n (%) 7 (17.5)
Additional diagnoses, n (%)
 Pancreatic insufficiency, n (%) 5 (12.5)
Small intestinal bacterial overgrowth, n (%) 13 (32.5)
 Using a bile acid sequestrant, n (%) 25 (62.5)
SeHCAT 7-day retention, n (%) Severe: 0 – <5% Moderate: 5 – <10% Mild: 10 – <15% Borderline: 15 – 20% 20 (50.0) 7 (17.5) 10 (25.0) 3 (7.5)

asurgical procedures for GI luminal surgery: 40-cm ileum and caecum resected; gastrojejunostomy and ileocolic bypass, length resected unknown; ileocolic resection, length resected unknown; cholescystectomy and small bowel resection, length unknown; 25-cm jejunum, 25-cm ileum and right colon removed; gastrectomy and splenectomy; 30-cm terminal ileum resected; right hemicolectomy, length resected unknown; rectal surgery, anterior resection only; 8-cm terminal ileum, 70-cm distal jejunum, 19-cm proximal jejunum; ileal surgery, extent unknown; 25-cm small bowel resected and right hemicolectomy; right hemicolectomy, 16-cm terminal ileum, caecum and 57.5-cm colon; total mesorectal excision; previous gastric bypass. GI = gastrointestinal; SD = standard deviation; SeHCAT = 75selenium homocholic acid taurine.